PD-L1, an immunosuppressive protein, is overexpressed in lung tumors, according to accumulating evidence, and inhibiting this pathway has provided long-lasting relief for some patients with advanced-stage NSCLC (16). The gene discussed is CD274; the disease is non-small cell lung carcinoma.